ISB News

New Study: Using Single-Cell Technology to Predict Cell Behavior

In a study published in PLOS BIOLOGY, researchers at Institute for Systems Biology (ISB) explain how they developed a new theory for predicting cell-fate decisions and demonstrate, for the first time, that cells indeed undergo a critical transition – or tipping point – when they commit to a particular lineage.

Jan. 9, 2017

3 Bullets:

  • ISB researchers developed a new theory that uses state-of-the-art single-cell technology to make predictions about how cells will behave in the future.
  • The method can predict when a cell will experience a so-called tipping point before it happens.
  • Being able to predict these critical transitions in cells may have life-saving ramifications in the ability to detect early warning signals for disease.

By Dr. Sui Huang

Stem cells hold enormous potential for cell-based therapy in regenerative medicine, if we can use drugs in the lab to push the patient’s own stem cells to become desired cell types, such as blood, liver, or heart cells. So far, our successes in controlling the generation of specific cell types have been empirical. Researchers have painstakingly mapped out many of the genes involved in the cell-fate-decision processes. But we still have little clue about the fundamental principles that govern how a multipotent stem cell, which has the potential to become more than one type of cell, makes a decision to become a specific cell type. We have not had a formal theory for such cell-fate decisions – until now.

In a study published in PLOS BIOLOGY, researchers at Institute for Systems Biology (ISB) explain how they developed a new theory for predicting cell-fate decisions and demonstrate, for the first time, that cells indeed undergo a critical transition – or tipping point – when they commit to a particular lineage. The team designed a new computational approach that utilizes single-cell resolution gene-expression profiling data to compute an index that indicates an imminent tipping point in cells before it happens. READ MORE….

Recent Articles

  • Dr. Hadlock

    Dr. Jennifer Hadlock Promoted to Associate Professor

    Dr. Jennifer Hadlock – an expert in machine learning, immune-mediated inflammatory disease, and maternal/fetal health – has been promoted to associate professor. The Hadlock Lab is an interdisciplinary team that aims to accelerate translational research by integrating clinical data into systems biology at scale.

  • Spotlight on ISB Education graphic

    2022-23 School Year ISB Education Highlights

    From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2022-2023 academic year, we will highlight some of the top projects the team is working on.

  • Beyond the Scale: How Multiomics and Biological BMI Can Help Achieve Optimal Health

    ISB researchers have constructed a biological BMI that provides a more accurate representation of metabolic health and is more varied, informative and actionable than the long-used classical BMI. ISB Senior Research Scientist Dr. Noa Rappaport discussed biological BMI in a Research Roundtable presentation.